an innovative clinical stage biotechnology company that is developing novel pain relief treatments for osteoarthritis
Ygal Rotenstreich, MD
Ifat Sher, PhD
CEO, DALI Medical Devices
CTO, DALI Medical Devices
Enhancing delivery of therapies to the back of
Everads Therapy is an early-stage life sciences company developing the next generation of retinal treatment delivery technologies.
With the goal of overcoming significant challenges in current treatment methodologies for retinal and macular diseases, Everads' delivery system offers the promise of improving the efficacy and safety of existing and potential drug therapies.
Established in 2017, Everads Therapy operates within the RAD Biomed incubator in Tel Aviv, Israel. Its underlying technologies have been licensed from the Sheba Medical Center at Tel Hashomer.